Targeting Lipid Metabolism in Metastatic Prostate Cancer

Scientists explore the epidemiological links between obesity and metabolic syndrome and prostate cancer (PCa), the evidence for altered circulating lipids in PCa and their potential role as biomarkers, as well as novel therapeutic strategies for targeting lipids in men with PCa.